Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New protein variant underlies the ability of gastric cancers to resist chemotherapy

New protein variant underlies the ability of gastric cancers to resist chemotherapy

New genetic technology for gene expression analysis of cancer cells

New genetic technology for gene expression analysis of cancer cells

DNA sequencing of residual disease accurately identifies leukemia patients who would relapse

DNA sequencing of residual disease accurately identifies leukemia patients who would relapse

Novel anti-inflammatory drug target identified by CRISPR

Novel anti-inflammatory drug target identified by CRISPR

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

NYU Langone opens new state-of-the-art center to treat patients with blood cancers

NYU Langone opens new state-of-the-art center to treat patients with blood cancers

Research reveals how disordered protein interaction orchestrates gene expression

Research reveals how disordered protein interaction orchestrates gene expression

Combination of two targeted drugs shows "clinically meaningful" activity in some malignant brain tumors

Combination of two targeted drugs shows "clinically meaningful" activity in some malignant brain tumors

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Study uncovers important genetic predispositions for acute myeloid leukemia

Study uncovers important genetic predispositions for acute myeloid leukemia

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

Donor cells with clonal hematopoiesis may improve bone marrow transplant outcomes

Donor cells with clonal hematopoiesis may improve bone marrow transplant outcomes

AI could help better diagnose blood diseases

AI could help better diagnose blood diseases

Study identifies key factor sustaining malignant tumor state

Study identifies key factor sustaining malignant tumor state

UC researchers engineer new probiotic to target and break down cancer cell defenses

UC researchers engineer new probiotic to target and break down cancer cell defenses

Experts develop a functional precision medicine approach to assign therapies to cancer patients

Experts develop a functional precision medicine approach to assign therapies to cancer patients

New metabolic vulnerabilities of subsets of triple-negative breast cancer discovered

New metabolic vulnerabilities of subsets of triple-negative breast cancer discovered

COVID-19 booster shot extremely beneficial for most cancer patients

COVID-19 booster shot extremely beneficial for most cancer patients

New research finds disturbing lack of crucial blood cancer medication

New research finds disturbing lack of crucial blood cancer medication

Study provides a new target for therapeutic intervention in Parkinson's disease

Study provides a new target for therapeutic intervention in Parkinson's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.